NCT05499663

Brief Summary

At the end of cancer treatment, many patients are still dealing with symptoms of cancer and side effects of treatment. Many are also left in a surreal mental state with uncertainty regarding the future of their health. Survivorship Care Plans are plans that are provided to individuals at the completion of cancer treatment (i.e., chemotherapy, surgery, radiation). Survivorship Care Plans describe the details of a person's diagnosis and treatment, as well as provide recommendations for follow-up appointments, referrals, and healthy behaviors to accelerate recovery and prevent recurrence (e.g., diet, exercise, smoking cessation). Survivorship Care Plans are currently static documents that are provided via paper and become outdated as soon as the person's health status changes. Therefore, there is a need to digitize Survivorship Care Plans to improve the accessibility, modifiability, and longevity of the plan. In addition, with current technology, there is an opportunity for Survivorship Care Plans to be linked with mobile devices and activity trackers so that people can track health behaviors and compare them to their clinical goals, enabling people to take charge of their own health. Charles River Analytics developed an app called POSTHOC (POST-treatment Healthcare Outcomes for Cancer survivors) that digitizes the Survivorship Care Plan with goals to integrate it into the digital medical record. Herein, phase I/II feasibility/preliminary efficacy randomized controlled trial is being conducted among 54 patients with cancer who recently completed adjuvant treatment for cancer (e.g., chemotherapy, radiotherapy, surgery) to compare 12 weeks of the POSTHOC app as part of the Survivorship Care Plan vs. the usual care Survivorship Care Plan on total symptom burden. Participants will be randomized 2:1, POSTHOC:usual care. All participants will be asked to download the POSTHOC app to assess technical compatibility and for data collection purposes (i.e., step count via Fitbit, ecological momentary assessment). All participants will have a "lite" version of the app for baseline. Upon randomization, those randomized to the POSTHOC group will be provided with their Survivorship Care Plan via the app, and will choose to focus on nutrition or exercise for the duration of the study, based on their individual plan and personal preferences. These features will also become accessible in the app. At baseline, 6 weeks, and 12 weeks, patient-reported outcomes will be evaluated including total symptom burden, diet, and physical activity. Extensive quantitative and qualitative feedback will also be collected on the usability of the app from those in the POSTHOC arm in order to improve the app for future implementation studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 12, 2022

Completed
1.6 years until next milestone

Study Start

First participant enrolled

March 5, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 11, 2025

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2025

Completed
11 months until next milestone

Results Posted

Study results publicly available

February 6, 2026

Completed
Last Updated

February 6, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

August 10, 2022

Results QC Date

December 17, 2025

Last Update Submit

February 5, 2026

Conditions

Keywords

mobile healthmhealthexercisenutritionbehavior change

Outcome Measures

Primary Outcomes (5)

  • Number of Participants Who Logged Data at Least Three Times in the POSTHOC App

    Number of participants who logged data at least three times in the POSTHOC app

    12 weeks

  • Usefulness of POSTHOC App

    7-point Likert scale for usefulness flanked by 1=not at all useful and 7=extremely useful

    6 weeks

  • Usefulness of POSTHOC App

    7-point Likert scale for usefulness flanked by 1=not at all useful and 7=extremely useful

    12 weeks

  • Likely to Recommend the POSTHOC App

    7-point Likert scale flanked by 1=not at all likely to recommend to others and 7=extremely likely

    6 weeks

  • Likely to Recommend the POSTHOC App

    7-point Likert scale flanked by 1=not at all likely to recommend to others and 7=extremely likely

    12 weeks

Secondary Outcomes (2)

  • Cumulative Symptom Burden

    6 weeks

  • Cumulative Symptom Burden

    12 weeks

Study Arms (2)

POSTHOC app

EXPERIMENTAL
Behavioral: POSTHOC app

Control

NO INTERVENTION

Interventions

POSTHOC appBEHAVIORAL

The POSTHOC app is a smartphone application that will deliver the Survivorship Care Plan and promote healthy lifestyle behaviors consistent with the individual's Care Plan

POSTHOC app

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have had a cancer diagnosis (any type)
  • Will soon or have recently completed treatment (within the past 12 weeks) with chemotherapy, radiotherapy, or surgery with curative intent
  • Must have received, plans to receive, or open to receiving a Survivorship Care Plan (SCP) as per their provider
  • Have access to a device capable of running the POSTHOC app and Fitbit app (e.g., Android or Apple smartphone) and reliable Internet access
  • Be at least 18 years of age
  • Be able to read and understand English, and
  • Be able to provide written informed consent

You may not qualify if:

  • Have planned surgery, radiotherapy, or surgery during the study period (hormonal and biologic therapy is allowed)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland, Baltimore

Baltimore, Maryland, 21201, United States

Location

Related Publications (2)

  • James S, Clingan CL, Adesanya IA, Zhu S, Francis ME, Rosenblatt PY, Molitoris JK, Deighton DC, Winder AT, Desrochers PC, McGeorge NM, Kleckner IR, Kleckner AS. Leveraging technology to address POST-Treatment Health Outcomes of Cancer Survivors (POSTHOC): A phase I/II randomized controlled trial of a survivorship care plan mobile application. J Cancer Surviv. 2025 Nov 27:10.1007/s11764-025-01946-7. doi: 10.1007/s11764-025-01946-7. Online ahead of print.

  • Chung KH, Youngblood SM, Clingan CL, Deighton DC, Jump VA, Manuweera T, McGeorge NM, Renn CL, Rosenblatt PY, Winder AT, Zhu S, Kleckner IR, Kleckner AS. Digitizing Survivorship Care Plans Through the POST-Treatment Health Outcomes of Cancer Survivors (POSTHOC) Mobile App: Protocol for a Phase II Randomized Controlled Trial. JMIR Res Protoc. 2024 Sep 5;13:e59222. doi: 10.2196/59222.

MeSH Terms

Conditions

NeoplasmsSigns and SymptomsMotor Activity

Condition Hierarchy (Ancestors)

Pathological Conditions, Signs and SymptomsBehavior

Limitations and Caveats

For 10 consented participants, app download was unsuccessful.

Results Point of Contact

Title
Amber Kleckner
Organization
University of Maryland School of Nursing

Study Officials

  • Amber Kleckner, PhD

    University of Maryland, Baltimore

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 10, 2022

First Posted

August 12, 2022

Study Start

March 5, 2024

Primary Completion

March 11, 2025

Study Completion

March 20, 2025

Last Updated

February 6, 2026

Results First Posted

February 6, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations